Function and Modulation of Type I Interferons during Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory infections in infants and young children, accounting for an estimated 3 million hospitalizations annually worldwide. Despite the major health burden, there is currently no licensed RSV vaccine. RSV is recognized by a range o...
Main Authors: | Laura M. Stephens, Steven M. Varga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/2/177 |
Similar Items
-
Reevaluating the Impact of Epstein-Barr Virus Noncoding RNAs on the Interferon Response
by: Eain A. Murphy
Published: (2021-08-01) -
Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity
by: Diego R. Hijano, et al.
Published: (2019-03-01) -
The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
by: Alexey A. Lozhkov, et al.
Published: (2020-11-01) -
NRF2 Antioxidant Response and Interferon-Stimulated Genes Are Differentially Expressed in Respiratory-Syncytial-Virus- and Rhinovirus-Infected Hospitalized Children
by: Leonardo Sorrentino, et al.
Published: (2023-04-01) -
Autophagy, TGF-beta and SMAD-2/3 signaling regulates interferon-beta response in respiratory syncytial virus infected macrophages
by: Swechha Pokharel, et al.
Published: (2016-12-01)